Cencora, Inc.

COR Healthcare Medical Distribution

Cencora, Inc.’s revenue for fiscal 2026 (year ended September 2026) was $337.4 billion, up 5.00% from fiscal 2025.

Revenue
+5.52%
EPS
+258.4%
Free cash flow
−7.81%
Total debt
+47.1%

Quarter to September 2026, against a year earlier

334.30 5.38 −1.58%
Market cap
$64.8B
P/E
18.8×
Fwd P/E
17.5×
Dividend yield
0.71%
F-score
7/9
Altman Z
n/a
Beneish M
−2.59
Dividend safety
70/100

Cencora, Inc. (COR) P/E ratio

Alert me on P/E ratio

As of 5 November 2026, Cencora, Inc. (COR) trades at a P/E ratio of 18.8×. Over the past ten years it has ranged from 0.0× (September 2021) to 1,035× (March 2015); the current reading is higher than 48% of that period. That is below the Healthcare sector median of 25.2×.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2026 16.6× (57.30%)
FY2025 39.0× 31.24%
FY2024 29.7× 42.77%
FY2023 20.8× 25.11%
FY2022 16.6× 4.11%
FY2021 16.0× —
FY2020 0.0× —
FY2019 20.2× 65.68%
FY2018 12.2× (72.15%)
FY2017 43.8× 268.52%

Quarterly newest first

Period P/E ratio Change
Sep 2026 16.6× (20.49%)
Jun 2026 20.9× (12.58%)
Mar 2026 23.9× (40.59%)
Dec 2025 40.3× 3.43%
43 more quarters

Against its own ten years

Low 0.0× High 1,035×
Ten-year median 19.3×
Current reading's percentile 39

P/E ratio against peers

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on COR